Indegene announced its subsidiaries, Indegene, Inc. (USA) and Trilogy Writing and Consulting GmbH, signed an agreement on December 31, 2025, to acquire 100 equity shares in Trilogy Writing Consulting Inc. (formerly Trilogy Writing and Consulting ULC (Canada)). This acquisition will make Trilogy Canada, a specialist in medical writing, a wholly owned subsidiary of Indegene, Inc., moving it from its previous ownership under Trilogy Writing and Consulting GmbH.